The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Open accessAbstract
Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in brains of individuals with Alzheimer's disease (AD) and other tauopathies. Tau pathology is critical to pathogenesis and correlates to the severity of dementia. However, the mechanisms leading to abnormal hyperphosphorylation are unknown. Here, we demonstrate that human brain tau was modified by O-GlcNAcylation, a type of protein O-glycosylation by which the monosaccharide β- N -acetylglucosamine (GlcNAc) attaches to serine/threonine residues via an O-linked glycosidic bond. O-GlcNAcylation regulated phosphorylation of tau in a site-specific manner both in vitro and in vivo . At most of the phosphorylation sites, O-GlcNAcylation negatively regulated tau phosphorylation. In an animal model of starved mice, low glucose uptake/metabolism that mimicked those observed in AD brain produced a decrease in O-GlcNAcylation and consequent hyperphosphorylation of tau at the majority of the phosphorylation sites. The O-GlcNAcylation level in AD brain extracts was decreased as compared to that in controls. These results reveal a mechanism of regulation of tau phosphorylation and suggest that abnormal hyperphosphorylation of tau could result from decreased tau O-GlcNAcylation, which probably is induced by deficient brain glucose uptake/metabolism in AD and other tauopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a reduction of glucose consumption induces an increase in phospho-Tau and A β accumulation (Fu et al., 2015; Liu et al., 2004).”
From Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease (2024) · cites this paper as Liu et al., 2004
Experimental — accuracy not yet measuredIn the citing paper
“For example, reduced tau O-glycosylation could lead to increased phosphorylation, while the enhancement of O-glycosylation reduces the extent of tau phosphorylation [43–45].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
In the citing paper
“As discussed above, a reciprocal relationship has been found between O-GlcNAcylation and phosphorylation on tau [43].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
Self-citationA68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Köpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779
Self-citation
Flagged first, then by citations
1 of the 42 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Roos, M. D., Xie, W., Su, K., Clark, J. A., Yang, X., Chin, E., Paterson, A. J. & Kudlow, J. E. (1998) Proc. Assoc. Am. Physicians 110, 422-432.9756093
- Iqbal, K. & Grundke-Iqbal, I. (2000) Neurosci. News 3, 14-20.
- Xavier-Blaizot, A., Meguro, K., Millien, I., Baron, J.-C. & Chavoix, C. (2002) J. Neurosci. 21, 9166-9170.
Cited by
Sorted by citations
Items 501–600 of 781
Therapeutic strategies for tauopathies and drug repurposing as a potential approach
Islam, M., Shen, F., Regmi, D., & Du, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114979 · Cited by 14
The pivotal nature of sugars in normal physiology and disease
Alavi, A., & Axford, J. S. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-005-0247-4 · Cited by 14
Diwu, Y., Tian, J., & Shi, J. (2013) · 中医杂志：英文版 · doi:10.1016/s0254-6272(13)60180-6 · Cited by 13
Simple method for O-GlcNAc sensitive detection based on graphene quantum dots
Gao, L., Wang, Y., Lu, M., Fa, M., Yang, D., & Yao, X. (2017) · RSC Advances · doi:10.1039/c7ra02643a · Cited by 13
González‐García, P., Díaz-Casado, M. E., Hidalgo‐Gutiérrez, A., Jiménez-Sánchez, L., Bakkali, M., Barriocanal‐Casado, E., Escames, G., Chiozzi, R. Z., Völlmy, F., Zaal, E. A., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102403 · Cited by 13
Canterini, S., Carletti, V., Nusca, S., Mangia, F., & Fiorenza, M. T. (2013) · FEBS Journal · doi:10.1111/febs.12123 · Cited by 13
Hiratå, Y., Nakagawa, T., Moriwaki, K., Koubayashi, E., Kakimoto, K., Takeuchi, T., Inoue, T., Higuchi, K., & Asahi, M. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-106 · Cited by 14
Demystifying O-GlcNAcylation: hints from peptide substrates
Shi, J., Ruijtenbeek, R., & Pieters, R. J. (2018) · Glycobiology · doi:10.1093/glycob/cwy031 · Cited by 13
Developing Trojan horses to induce, diagnose and suppress Alzheimer’s pathology
Aziz, A. A., & Amtul, Z. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104471 · Cited by 12
Pedowitz, N. J., Zaro, B. W., & Pratt, M. R. (2020) · Current Protocols in Chemical Biology · doi:10.1002/cpch.81 · Cited by 13
Jones, S. P. (2005) · Circulation Research · doi:10.1161/01.res.0000168039.61228.67 · Cited by 13
Tau in Alzheimer's disease: Shaping the future patient journey
Mummery, C. J., Li-Hsian, C. C., Lasagna‐Reeves, C. A., Ossenkoppele, R., Rowe, C. C., Scharre, D. W., Wang, H., Kyaga, S., & Cummings, J. L. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100447 · Cited by 15
Ahmad, W., Shabbiri, K., & Ahmad, I. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.176 · Cited by 12
Wang, X., Cao, J.-F., Zhang, X., Shu, Y., & Wang, J. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463183 · Cited by 12
Tawada, M., Fushimi, M., Masuda, K., Sun, H., Uchiyama, N., Kosugi, Y., Lane, W., Tjhen, R., Endo, S., & Koike, T. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01712 · Cited by 12
O-GlcNAc cycling mediates energy balance by regulating caloric memory
Andersson, B., Tan, E. P., McGreal, S. R., Apte, U. M., Hanover, J. A., Slawson, C. M., & Lagerlöf, O. (2021) · Appetite · doi:10.1016/j.appet.2021.105320 · Cited by 11
Regulation of Primary Cilium Length by O-GlcNAc during Neuronal Development in a Human Neuron Model
Tian, J. L., Huang, C., Eslami, F., Mannino, M. P., Lee, R., & Hart, G. W. (2023) · Cells · doi:10.3390/cells12111520 · Cited by 12
Self-citationBottoni, A., Miscione, G. P., & Calvaresi, M. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp02308f · Cited by 12
The sweet tooth of the circadian clock
Fu, M., & Yang, X. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160183 · Cited by 11
Fontelle, N., Yamamoto, A., Ardá, A., Jiménez‐Barbero, J., Kato, A., Désiré, J., & Blériot, Y. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201800678 · Cited by 12
Progress in the treatment of Parkinson-Plus syndromes
Olfati, N., Shoeibi, A., & Litvan, I. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.10.006 · Cited by 16
Landrieu, I., Dupré, E., Sinnaeve, D., Hajjar, L. E., & Smet‐Nocca, C. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.886382 · Cited by 12
Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13
Alhadidy, M. M., Stemmer, P. M., & Kanaan, N. M. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108263 · Cited by 13
SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits
Bi, A., An, W., Wang, C., Hua, Y. F., Fang, F., Dong, X., Chen, R., Zhang, Z., & Luo, L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108027 · Cited by 12
Unique Tauopathy in Fukuyama-Type Congenital Muscular Dystrophy
Saito, Y., Motoyoshi, Y., Kashima, T. G., Izumiyama‐Shimomura, N., Toda, T., Nakano, I., Hasegawa, M., & Murayama, S. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000190069.10633.c2 · Cited by 11
Structural studies of a surface-entropy reduction mutant of O-GlcNAcase
Males, A., & Davies, G. J. (2019) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318016595 · Cited by 11
Lee, H. E., Lim, D., Lee, J. Y., Lim, S. M., & Pae, A. N. (2019) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2019-0003 · Cited by 11
Britto‐Borges, T., & Barton, G. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184405 · Cited by 11
TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease
Ceyzériat, K., Badina, A. M., Abjean, L., Meyer, L., Bouteldja, F., Bałkota, M., Amossé, Q., Prudhomme, O., Middleton, R. J., Liu, G.-J., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03583-4 · Cited by 14
Targeting necroptosis in Alzheimer’s disease: can exercise modulate neuronal death?
Lu, D., Zhang, W., Li, R., Tan, S., & Zhang, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1499871 · Cited by 13
Updates on Tau-Related Drug Targets and Potential Disease-Modifying Therapies for Alzheimer Disease
Djurovic-Topalovic, A., Horgan, N. G., & Fortin, J. S. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.020 · Cited by 10
Sena, P. P., Weber, J. J., Watchon, M., Robinson, K. J., Wassouf, Z., Hauser, S., Helm, J., Abeditashi, M., Schmidt, J., Hübener‐Schmid, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025810118 · Cited by 10
Electron transfer in protein modifications: from detection to imaging
Zhang, L., Chu, M., Ji, C., Wang, W., Tan, J., & Yuan, Q. (2023) · Science China Chemistry · doi:10.1007/s11426-022-1417-3 · Cited by 10
A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts
Amand, M. M. S., Bond, M. R., Riedy, J., Comly, M. E., Shiloach, J., & Hanover, J. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004059 · Cited by 10
Brain glucose transporter protein 2 and sporadic Alzheimer’s disease
Šalković‐Petrišić, M., & Riederer, P. F. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0030-y · Cited by 10
Fourneau, J., Canu, M., Cieniewski‐Bernard, C., Bastide, B., & Dupont, E. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14474 · Cited by 10
Bergeron‐Brlek, M., Goodwin‐Tindall, J., Cekic, N., Roth, C., Zandberg, W. F., Shan, X., Varghese, V., Chan, S., Davies, G. J., Vocadlo, D. J., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201507985 · Cited by 10
Xiong, Q., Li, F., Chi, H., Yang, Y., Li, M., Liu, Y., Zhang, Y., Leng, B., Qi, X., Sun, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad764 · Cited by 10
Yu, H., Chen, X., Yang, Y., Gu, M., Ren, K., & Wei, Z. (2025) · The FASEB Journal · doi:10.1096/fj.202502809r · Cited by 9
Targeting tau in Alzheimer’s Disease: rationale, approach and challenges
Aslanyan, A., Foiani, M. S., Giovannucci, T. A., McDade, E., Duff, K., Mummery, C. J., Schöll, M., Wildsmith, K. R., & Paterson, R. W. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00925-5 · Cited by 10
Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype
Uygar, B., & Lagerlöf, O. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_9 · Cited by 11
Kammula, S. V., Tripathi, S., Wang, N., Dawson, V. L., Dawson, T. M., & Mao, X. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.20 · Cited by 9
Ma, D., & Li, L. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.20 · Cited by 9
Liu, B., Yan, Y., Liang, H., Tang, K., & Ding, C. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462285 · Cited by 9
Gao, L., Zhao, R., Wang, Y., Lu, M., Yang, D., Fa, M., & Yao, X. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.07.058 · Cited by 9
Rani, L., & Mallajosyula, S. S. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c09419 · Cited by 8
Krüger, L., Biskup, K., Schipke, C. G., Kochnowsky, B., Schneider, L., Peters, O., & Blanchard, V. (2024) · Biomolecules · doi:10.3390/biom14050512 · Cited by 9
Lei, H., Lv, J., Zhang, F., Wei, L., Shi, K., Liu, J., He, T., Xiong, R., Sun, F., Zhong, T., et al. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00473-w · Cited by 9
Overview of Proteomic Analysis of Amyloid Plaques and Neurofibrillary Tangles in Alzheimer’s Disease
Grewal, A., Raikundalia, S., Zaia, J., & Sethi, M. K. (2025) · Biomolecules · doi:10.3390/biom15091310 · Cited by 9
Dasari, S., & Kalyaanamoorthy, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02109 · Cited by 8
Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
Sayas, C. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00005-7 · Cited by 9
Galesic, A., & Pratt, M. R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0434-2_15 · Cited by 8
Gupta, S., Jinka, S. K. A., Khanal, S., Bhavnani, N., Almashhori, F., Lallo, J., Mathias, A., Al‐Rhayyel, Y., Herman, D. E., Holden, J. G., et al. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25196 · Cited by 8
Davies, G. J., & Martinez-Fleites, C. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381179 · Cited by 8
Recall sugars, forget Alzheimer's
Lefebvre, T. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.920 · Cited by 8
Ren, X., Jiang, S., Li, D., Sun, H. Z., & Wang, D. (2013) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309113011639 · Cited by 8
Navigating the treatment landscape of Alzheimer's disease: Current strategies and future directions
Mohapatra, T. K., Nayak, R. R., Ganeshpurkar, A., Tiwari, P. K., & Kumar, D. (2025) · Ibrain · doi:10.1002/ibra.12197 · Cited by 8
Comprehensive Evaluation of Cleavable Bioorthogonal Probes for Site-Specific O-GlcNAc Proteomics
Hou, C., Zhang, H., Deng, J., Wang, X., Byers, S. W., Levi, M., Pak, D. T. S., Moremen, K. W., Pei, H., Hart, G. W., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101064 · Cited by 7
Self-citationLei, H., Chen, X., Ruan, L., Liu, X., Ye, F., Li, K., Cheng, W., Yu, B., Di, C., & Di, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102927 · Cited by 7
Protein O‐GlcNAcylation in Health and Diseases
Ran, Z., Chen, C., Ou, J., Wu, G., Yang, C., & Liu, X. (2025) · MedComm · doi:10.1002/mco2.70536 · Cited by 8
Torpor induces reversible tau hyperphosphorylation and accumulation in mice expressing human tau
Mestdagh, C. F. D. V., Witte, M. E., Scheper, W., Smit, A. B., Henning, R. H., & van Kesteren, R. E. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01800-4 · Cited by 7
Bell, M. B., Kane, M. S., Ouyang, X., Young, M. E., Jegga, A. G., Chatham, J. C., Darley-Usmar, V. M., & Zhang, J. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16302 · Cited by 11
Ferjancic, Z. B., & Saičić, R. N. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100398 · Cited by 7
Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways
Eldeeb, M. A., Ragheb, M. A., Soliman, M. H., & Fahlman, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-021-00396-0 · Cited by 9
Liu, F., Li, S., Zhao, X., Xue, S., Li, H., Yang, G., Li, Y., Wu, Y., Zhu, L., Chen, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12040806 · Cited by 7
Self-citationGozes, I. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0029-y · Cited by 7
Huang, R., Tian, S., Han, J., Cai, R., Lin, H., Guo, D., Wang, J., & Wang, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00110 · Cited by 7
Yuzwa, S. A., & Vocadlo, D. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_13 · Cited by 7
Nedelkov, D., Tsokolas, Z. E., Rodrigues, M. S., Sible, I. J., Han, S. D., Kerman, B. E., Renteln, M., Mack, W. J., Pascoal, T. A., Yassine, H. N., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01795-7 · Cited by 6
Yang, W., Wu, J., & Cui, G. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003939 · Cited by 6
Relationship Between O-GlcNAcase Expression and Prognosis of Patients With Osteosarcoma
Sombutthaweesri, T., Wu, S., Chamusri, N., Settakorn, J., Pruksakorn, D., Chaiyawat, P., Sastraruji, T., Krisanaprakornkit, S., & Supanchart, C. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000970 · Cited by 8
Mind the Metabolic Gap: Bridging Migraine and Alzheimer's disease through Brain Insulin Resistance
Moro, L. D., Pirovano, E., & Rota, E. (2024) · Aging and Disease · doi:10.14336/ad.2024.0351 · Cited by 7
Role of O-GlcNAcylation in Alzheimer's disease: Insights and perspectives
Sharma, A., Singh, A., Debnath, R., Gupta, G. D., & Sharma, K. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100195 · Cited by 7
Mechanistic Insights into the Hydrolysis of O-GlcNAcylation Catalyzed by Human O-GlcNAcase
Xiong, J., & Xu, D. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c05755 · Cited by 6
Chen, X., Raimi, O. G., Ferenbach, A. T., & van Aalten, D. M. F. (2020) · FEBS Letters · doi:10.1002/1873-3468.13968 · Cited by 6
Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00006-x · Cited by 7
Hajjar, L. E., Bridot, C., Nguyen, M., Cantrelle, F., Landrieu, I., & Smet‐Nocca, C. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_15 · Cited by 6
Historical perspectives on the discovery and development of drugs to treat neurological disorders
Williams, M. J., & COYLE, J. T. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.008 · Cited by 6
Issad, T., & Pagésy, P. (2014) · Biologie Aujourd hui · doi:10.1051/jbio/2014015 · Cited by 6
An Improved Route to PUGNAc and Its Galacto-Configured Congener
Goddard‐Borger, E. D., & Stubbs, K. A. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo100614b · Cited by 6
Effect of Peripheral Insulin Administration on Phosphorylation of Tau in the Brain
Jiang, Y., Li, L., Dai, C., Zhou, R., Gong, C., Iqbal, K., Gu, J., & Liu, F. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200147 · Cited by 6
Self-citationDésiré, J., Foucart, Q. P. O., Poveda, A. M., Gourlaouen, G., Shimadate, Y., Kise, M., Proceviat, C., Ashmus, R. A., Vocadlo, D. J., Jiménez‐Barbero, J., et al. (2021) · Carbohydrate Research · doi:10.1016/j.carres.2021.108491 · Cited by 6
dos Santos, V. L. P., Franco, C. R. C., Wagner, R., Silva, C. D., Favretto, G., da Cunha, R. S., Stinghen, A. E. M., Monteiro, L. M., Bussade, J. E., Manfron, J., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i4.13289 · Cited by 6
Tau Protein Associated Inhibitors in Alzheimer Disease
Li, Q., Chu, T., Chen, Y., & Li, Y. (2014) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201400469 · Cited by 6
Britto‐Borges, T., & Barton, G. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190461 · Cited by 6
Bell, M., Kane, M. S., Ouyang, X., Young, M. E., Jegga, A. G., Chatham, J. C., Darley-Usmar, V. M., & Zhang, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.19.613769 · Cited by 6
Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 6
Thomas, S., & Prendergast, G. C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1183932 · Cited by 8
Zhang, L., Deng, T., Pan, S., Zhang, M., Zhang, Y., Yang, C., Yang, X., Tian, G., & Mi, J. D. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1456728 · Cited by 6
Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5
C‐Terminal Tag Location Hampers in Vitro Profiling of OGT Peptide Substrates by mRNA Display
Shi, J., Sharif, S., Balsollier, C., Ruijtenbeek, R., Pieters, R. J., & Jongkees, S. A. K. (2020) · ChemBioChem · doi:10.1002/cbic.202000624 · Cited by 5
Serine phosphorylation mimics of Aβ form distinct, non-cross-seeding fibril morphs
Sanagavarapu, K., Meisl, G., Lattanzi, V., Bernfur, K., Frohm, B., Olsson, U., Knowles, T. P. J., Malmendal, A., & Linse, S. S. (2024) · Chemical Science · doi:10.1039/d3sc06343g · Cited by 5
Zuo, R., Liu, R., Olguin, J., & Hudalla, G. A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c02083 · Cited by 5
Tau and neurodegenerative disorders
Motoi, Y., Sahara, N., Kambe, T., & Hattori, N. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.017 · Cited by 5
Protein–Ligand Interaction Study of CpOGA in Complex with GlcNAcstatin
de Sousa, P. R. M., Alencar, N., Lima, A. H., Lameira, J., & Alves, C. N. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12078 · Cited by 5
Targeted tau protein degradation: a promising therapeutic approach for tauopathies
Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 5
O-GlcNAc and phosphorylation modifications on HtL1/FBA10 regulate wheat vernalization for flowering
Yang, P., Liu, Y. T., Dong, Q., Miao, Y., Zhang, J., Xu, S., Zhao, H., Niu, Y. D., Zhang, X., Xu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67734-0 · Cited by 4
Basli, A., & Bounaas, J. (2022) · Nutrition and Health · doi:10.1177/02601060221137104 · Cited by 4
August, I., Gagneux, P., Semendeferi, K., & Marchetto, M. C. (2025) · Evolutionary Anthropology Issues News and Reviews · doi:10.1002/evan.22054 · Cited by 4
Metadata
- Authors
- Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X.
- Affiliations
- Johns Hopkins University (US)
- Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314; and Department of Biological Chemistry, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205
- Corresponding author
- Gong, Cheng-Xin
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10804-10809
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490015
- OpenAlex
- W2164029759
- Cited by
- 775
- References
- 42
- Citations by year
- 2026: 29 · 2025: 50 · 2024: 38 · 2023: 36 · 2022: 44 · 2021: 63 · 2020: 57 · 2019: 38 · 2018: 46 · 2017: 45 · 2016: 33 · 2015: 23 · 2014: 36 · 2013: 24 · 2012: 35
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nanjing Medical University
- National Institutes of Health (HD13563)
- National Institute on Aging (AG19158, R01AG019158, AG16760, R01AG016760)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD013563, HD13563)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- O-GlcNAcylation, tau protein, tau hyperphosphorylation, Alzheimer's disease, tauopathy, neurofibrillary tangles, O-glycosylation, glucose metabolism, brain glucose uptake
- MeSH terms
- Acetylglucosamine, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Female, Glycosylation, Humans, Male, Mice, Inbred C57BL, Middle Aged, Phosphorylation, Starvation, PC12 Cells, tau Proteins, Rats, Wistar, Mice, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
